Logo

Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

Share this
Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

Phenomix Collaborates with Mayo Clinic for AI-Powered Obesity Phenotype Blood Test

Shots:

  • The Phenomix’s MyPhenome test utilize phenotype-driven multi-omics technology to analyze genomics- metabolomics- and hormone levels and use AI-driven algorithmic tool to identify four specific obesity phenotypes- giving doctors the ability to prescribe more precise anti-obesity treatments
  • The study showed that phenotype-specific obesity resulted in nearly double the weight loss over the treatment course of 1yr.
  • Phenomix has identified the four primary phenotypes i.e Hungry Brain- Hungry Gut- Emotional Hunger- and Slow Burn that encompass more than 90% of obesity cases. The company expects the launch of the MyPhenome test in 2021- once its CLIA laboratory process is complete

  Ref: BUSINESS WIRE | Image: Phenomix

Click here to­ read the full press release 

Tuba

Tuba was Senior Editor at PharmaShots. She was curious, creative, and passionate about recent updates and innovations in the life sciences industry. She covered Biopharma, MedTech, and Digital health segments. Tuba also had an experience in digital and social media marketing and ran the campaigns independently. She can be contacted at connect@pharmashots.com.

Share this article on WhatsApp, LinkedIn and Twitter

Join the PharmaShots family of 12000+ subscribers

I accept the Terms and Conditions